CVS Health Corp (CVS)
Healthcare | Health Care Plans
CEO: Larry J. Merlo
CVS Health Corp receives an in our proprietary multi-factor ranking approach that blends valuation, moat, operational performance, and financial strength. View the Top 50 tickrz ranked stocks here.
Valuation is the most heavily weighted component in our tickrz ranking methodology. Numerous academic and practitioner studies have found that a value approach outperforms the market over the long-run. CVS Health Corp's valuation score is comprised of a P/E ratio of 15.4x, a P/B ratio of 2.3x, a P/S ratio of 0.4x, and an EV/EBITDA ratio of 8.4x. .
WARREN BUFFETT RANKING
CVS Health Corp ranks 5 out of the S&P 500 constituents in our multi-factor Warren Buffett ranking methodology. This is a strong score, meaning it ranks highly on valuation, moat, volatility, and financial strength factors.
To calculate a company's Moat Score, we look at its historical earnings growth, historical average return on equity, the volatility of its earnings stream, and also factor in the strength of its balance sheet. CVS Health Corp appears to have a durable competitive advantage within the Healthcare sector.
CVS Health Corp has a Piotroski F Score of 6 out of 9. The F Score examines changes in profitability, leverage, liquidity, and operating efficiency. Interest coverage of 5.96x, a debt/equity ratio of 81% and a Moat Rank of 63 translate to a strong Financial Strength score.
Investment research has shown that stocks with strong performance over the last 6 to 12 months tend to perform better in the medium term than stocks with poor performance over the same period. In fact, the momentum factor is one of the strongest of all the investment factors.The company has seen its stock fall by -22.9% over the last 12 months. This performance is weak compared to other stocks in the S&P 500, earning it a rank of 479.
VALUE + YIELD
Shares currently yield 2.42%. Our dividend ranking approach looks at a company's dividend growth rate, payout ratio, business moat, and valuation. Based on our methodology, CVS Health Corp ranks 176 among the S&P 500 constituents.
A company's growth metrics are less important than its valuation, moat, and financial strength. However, a check on growth can be a good way to avoid companies in secular decline. Its 13.5% 5 year annualized EPS growth, 10.6% 5 year annualized sales-per-share growth, and 5 year annualized book value-per-share growth of 3.4% speak to its impressive growth ranking.